Da Vinci 5 receives CE mark for cardiac procedures
Intuitive re-introduces cardiac surgery in Europe as it becomes latest region in Intuitive’s global initiative to transform cardiac care with da Vinci 5
READING, UK, 22 September 2026: Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that its da Vinci 5 surgical system has received CE mark approval for adult cardiac surgery in Europe, including thoracoscopically-assisted cardiotomy procedures and minimally invasive coronary artery bypass procedures.1
Cardiovascular disease remains the leading cause of death worldwide, claiming nearly 18 million lives each year. 2 In 2022, it accounted for one-in-three deaths in the European Union.3 More than two million patients worldwide undergo open heart surgery annually4, with most procedures requiring a sternotomy, an approach that involves splitting the breastbone to open the chest and access the heart.
“This clearance represents our firm commitment to bring back robotic-assisted minimally invasive cardiac procedures in Europe. We are strongly aligned with our customers, offering new instrumentation suitable for cardiac procedures as well as a complete ecosystem – including global training, dedicated infrastructure and support – so surgeons and care teams can deliver better outcomes for their patients,” said Intuitive’s commercial president for Europe, Dirk Barten.
Robotic-assisted cardiac surgery has a long tradition in Europe; the first cardiac procedures with the da Vinci system were performed in France and Germany back in 1998. While early milestones demonstrated clinical potential, a combination of technical limitations and the absence of a dedicated training infrastructure led Intuitive to sequence its expansion around more adopted procedures. With da Vinci 5 CE-marked for cardiac surgery, and a mature ecosystem now in place, minimally invasive cardiac surgery is positioned to scale across Europe. Intuitive is reinforcing its long-term commitment through regulatory investment, partnerships with global cardiac societies to define dedicated training pathways, and da Vinci 5 as a future‑ready platform to help drive the transformation in cardiac surgery.
The design of da Vinci 5 can support minimally invasive cardiac procedures by enabling surgeons and their teams to operate through small incisions without opening the breastbone. The system offers:
“CE mark for adult cardiac procedures with da Vinci 5 is an important step in a broader global effort to help transform cardiac care,” said Intuitive’s global vice president of cardiac, Darla Hutton. “By bringing together 30 years of innovation, team-based training, and a service model built on reliability and safety, we believe we can help cardiac teams adopt robotic-assisted surgery in a way that is consistent, scalable and sustainable.”
To support adoption of cardiac surgery with da Vinci 5, Intuitive has established a dedicated team focused on building infrastructure, including the development of bespoke training programs, clinical evidence generation, and future cardiac-specific instruments and accessories. Intuitive will partner with a limited number of centers across Europe in 2026 and beyond to establish suitable, reproducible programs that create the foundation for long-term scale.
The value of the Intuitive system portfolio lies not only in individual products, but in how they work together – and in how we match the right systems to each customer’s surgical and institutional needs within the European healthcare system – connecting technology, education, insights, and optimization to enable sustainable, high-performing minimally invasive care across the patient pathway. The latest CE mark underscores this value and reinforces Intuitive’s commitment to help deliver sustainable minimally invasive care across Europe.
ENDS
Media contact
Bea Cadwallader, Intuitive,
E: bea.cadwallader@intusurg.com M: +44 7385 684197
Images
Images accompanying this announcement are available
here.
About Intuitive
Intuitive (NASDAQ:ISRG), headquartered in Sunnyvale, California, with UK & Ireland headquarters in Winnersh Triangle, Reading, is a global leader in minimally invasive care and the pioneer of robotic-assisted surgery. Our technologies include the da Vinci surgical system and the Ion endoluminal system. By uniting advanced systems, progressive learning, and value-enhancing services, we help physicians and their teams optimize care delivery to support the best outcomes possible. At Intuitive, we envision a future of care that is less invasive and profoundly better, where disease is identified early and treated quickly, so that patients can get back to what matters most.
About da Vinci Surgical Systems
There are several models of the da Vinci surgical system. The da Vinci surgical systems are designed to help surgeons perform minimally invasive surgery and offer surgeons high-definition 3D vision, a magnified view, and robotic and computer assistance. They use specialized instrumentation, including a miniaturized surgical camera and wristed instruments (i.e., scissors, scalpels, and forceps) that are designed to help with precise dissection and reconstruction deep inside the body.
For more information, please visit the company’s website at
This material may contain estimates and forecasts from which actual results may differ. Some products, features or technologies may not be available in all countries. Please contact your local Intuitive representative for product availability in your region. Refer to the product specific User Manual for indications, contraindications, warnings and other product information.